Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib

Erbil Dogan, Erbil Doğan, Uğur Saygılı, Uğur Saygili, Cemal Posacı, Cemal Posaci, Burçin Tuna, Burcin Tuna, Sezer Caliskan, Sezer Çalışkan, Sabahattin Altunyurt, Bahadir Saatli, Bahadır Saatli
Fertility and Sterility · 2004 · vol. 82 , pp. 1115–1120 · doi:10.1016/j.fertnstert.2004.06.033 · PMID:15474083 · W2102019784
article OA: bronze CC0 ⤵ 71 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

Rofecoxib, a cyclooxygenase-2 inhibitor, was administered to rats with endometrial explants and resulted in the regression of these explants.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Cyclooxygenase Inhibitors Endometriosis Lactones Administration, Oral Animals Ascitic Fluid Ascitic Fluid Atrophy Cyclooxygenase Inhibitors Endometriosis Endometriosis Endometriosis Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Injections, Subcutaneous Lactones Lactones Leuprolide Leuprolide

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (47)

Cited by (50)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:12:26.305326+00:00
License: CC0 · commercial use OK